| Literature DB >> 24977078 |
J C Schrama1, O Lutro2, H Langvatn1, G Hallan1, B Espehaug3, H Sjursen4, L B Engesaeter5, B-T Fevang6.
Abstract
High rates of Staphylococcus aureus are reported in prosthetic joint infection (PJI) in rheumatoid arthritis (RA). RA patients are considered to have a high risk of infection with bacteria of potentially oral or dental origin. One thousand four hundred forty-three revisions for infection were reported to the Norwegian Arthroplasty Register (NAR) from 1987 to 2007. For this study 269 infection episodes in 255 OA patients served as control group. In the NAR we identified 49 infection episodes in 37 RA patients from 1987 to 2009. The RA patients were, on average, 10 years younger than the OA patients and there were more females (70% versus 54%). We found no differences in the bacterial findings in RA and OA. A tendency towards a higher frequency of Staphylococcus aureus (18% versus 11%) causing PJI was found in the RA patients compared to OA. There were no bacteria of potential odontogenic origin found in the RA patients, while we found 4% in OA. The bacteria identified in revisions for infection in THRs in patients with RA did not significantly differ from those in OA. Bacteria of oral or dental origin were not found in infected hip joint replacements in RA.Entities:
Year: 2012 PMID: 24977078 PMCID: PMC4063173 DOI: 10.5402/2012/437675
Source DB: PubMed Journal: ISRN Orthop ISSN: 2090-6161
Overview of literature after year 2000 discussing whether rheumatoid arthritis patients are high risk patients for bacteremic prosthetic joint infection after dental treatment and therefore routinely needing antibiotic prophylaxis.
| Authors | Year of publication | Country | RA high risk patients, thus antibiotics |
|---|---|---|---|
| ADA and AAOS [ | 2003 | USA | Yes |
| Scott et al. [ | 2005 | Australia | Yes |
| Tong and Theis [ | 2008 | New Zealand | Yes |
| Kotze [ | 2008 | South Africa | Yes |
| Rompen et al. [ | 2008 | The Netherlands | Yes |
| AAOS [ | 2009 | USA | Yes |
| Kuong et al. [ | 2009 | Hong Kong | Yes |
| Seymour et al. [ | 2003 | Great Britain | No |
| Uçkay et al. [ | 2008 | Switzerland | No |
| Blomgren et al. [ | 2009 | Sweden | No |
| Berbari et al. [ | 2010 | USA | No |
Figure 1Flow chart showing the inclusion of patients for the study.
Patient characteristics.
| RA | OA |
| |
|---|---|---|---|
| Mean age (years) (SD)* | 64 (16) | 74 (8) | <0.001 |
| Sex (females%)** | 70% | 54% | 0.06 |
| Mean time to revision (years)* | 3.79 | 3.13 | 0.3 |
*In 318 infection episodes, **in the 292 patients.
Distribution of cultured bacteria at revision surgery in infected THR in RA patients versus OA patients.
| RA ( | OA ( |
| |
|---|---|---|---|
|
| 9 (18%) | 30 (11%) | 0.16 |
| Coagulase negative staphylococci | 9 (18%) | 79 (29%) | 0.11 |
| Streptococci | 1 (2%) | 19 (7%) | 0.33 |
| Enterococci | 1 (2%) | 18 (7%) | 0.33 |
| Gram negative bacteria | 3 (6%) | 10 (3%) | 0.43 |
| Others | 1 (2%) | 10 (3%) | 1.00 |
| Polymicrobial flora | 7 (14%) | 20 (7%) | 0.11 |
| No growth | 18 (37%) | 83 (31%) | 0.42 |
| Bacteria potentially of oral or dental origin | 0 | 12 (4%) | 0.13 |
∗Chi-square and Fisher's exact test.